According to the latest filing disclosed by the SEC, existing shareholders of biopharmaceutical company Tempest Therapeutics Inc. plan to resell up to 8.27 million shares of the company's common stock.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This stock resale plan was proactively initiated by selling shareholders, aiming to realize partial investment exit through the open market. The company itself is not participating in this stock offering, and therefore will not receive any direct financing proceeds from the stock resale. The document shows that the relevant shareholders have registered the resale qualification for these privately placed stocks, and specific transactions will be carried out opportunistically according to market conditions. As an innovative company in the clinical-stage oncology therapeutic sector, Tempest Therapeutics is currently advancing multiple anti-cancer therapy development projects. This equity change may trigger market attention on its capital structure.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Aave announces freezing of rsETH markets on V3 and V4
AIcoin•2026/04/18 20:07
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$75,709.16
-2.41%
Ethereum
ETH
$2,349.15
-3.53%
Tether USDt
USDT
$1
-0.02%
XRP
XRP
$1.43
-4.22%
BNB
BNB
$630.32
-1.85%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$86.12
-3.59%
TRON
TRX
$0.3297
+0.78%
Dogecoin
DOGE
$0.09475
-5.41%
Hyperliquid
HYPE
$43.97
-1.06%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now